- Home
- FDMT vs ITIC Comparison
FDMT vs ITIC Comparison
Compare FDMT & ITIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FDMT | ITIC |
|---|---|---|
| Founded | 2013 | 1972 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Specialty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 515.6M | 431.1M |
| IPO Year | 2019 | 1995 |
Fundamental Metrics
Financial Performance| Metric | FDMT | ITIC |
|---|---|---|
| Price | $9.66 | $233.60 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $31.71 | N/A |
| AVG Volume (30 Days) | ★ 800.7K | 15.3K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 4.53% |
| EPS Growth | ★ 18.79 | 13.02 |
| EPS | N/A | ★ 18.57 |
| Revenue | $85,209,000.00 | ★ $272,755,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $70.28 | N/A |
| P/E Ratio | ★ N/A | $12.56 |
| Revenue Growth | ★ 230194.60 | 5.60 |
| 52 Week Low | $2.96 | $190.20 |
| 52 Week High | $12.34 | $288.98 |
Technical Indicators
Market Signals| Indicator | FDMT | ITIC |
|---|---|---|
| Relative Strength Index (RSI) | 52.38 | 56.98 |
| Support Level | $8.41 | $230.57 |
| Resistance Level | $9.78 | $234.49 |
| Average True Range (ATR) | 0.60 | 5.69 |
| MACD | -0.01 | 2.19 |
| Stochastic Oscillator | 50.62 | 80.92 |
Price Performance
Historical ComparisonAbout FDMT 4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-710 and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector).
About ITIC Investors Title Company
Investors Title Co operates in the title insurance and exchange services sectors. The title insurance segment, conducted through ITIC and NITIC, offers title insurance policies for residential, commercial, and industrial properties in around 22 states and the District of Columbia, with a focus on the eastern United States. The title insurance segment issues title insurance policies through approved attorneys from underwriting offices and through independent issuing agents. Title insurance policies insure titles to real estate.n The Title Insurance segment contributes the majority of the company's revenue.